Avecho Biotechnology Limited (ASX:AVE)
Australia
· Delayed Price · Currency is AUD 0.0120
-0.0010 (-8.33%)
Mar 9, 2026, 4:10 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 44.08 million as of March 9, 2026. Its market cap has increased by 131.82% in one year.
Market Cap
44.08M
Enterprise Value
39.43M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 44.08M, an increase of 12.01%. That is a compound annual growth rate of 0.38%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EZZ Life Science Holdings | 51.07M |
| Entropy Neurodynamics | 53.31M |
| Proteomics International Laboratories | 53.68M |
| Amplia Therapeutics | 56.44M |
| Neurizon Therapeutics | 57.29M |
| NeuroScientific Biopharmaceuticals | 32.26M |
| Prescient Therapeutics | 63.09M |
| Argenica Therapeutics | 28.26M |